Medexus Announces 10% NCIB to Strengthen Shareholder Value
Toronto, Ontario & Chicago, Illinois — November 20, 2025 — Medexus Pharmaceuticals Inc. has announced that the Toronto Stock...
specialty pharmaceuticals
Advertisement
Advertisement
